MARC record from Internet Archive

LEADER: 03035cam 2200541 a 4500
001 ocm56012928
003 OCoLC
005 20210913005600.0
008 011116s2004 enka b 001 0 eng
040 $aNLM$beng$cNLM$dCUS$dOSU$dBAKER$dMUQ$dYDXCP$dBTCTA$dOCLCG$dDEBBG$dOCLCF$dOCLCO$dCASCU$dOCLCQ$dOCLCO$dOCLCQ$dTHHCU$dCNUTO$dIOD$dTHHCU$dAU@
015 $aGBA1U4445$2bnb
016 7 $a101219046$2DNLM
019 $a55991886
020 $a0853694834
020 $a9780853694830
035 $a(OCoLC)56012928$z(OCoLC)55991886
042 $apcc
050 4 $aRC931.O73$bF38 2004
060 00 $a2004 G-310
060 10 $aWE 250$bF353o 2004
082 04 $a616.716$221
084 $aVS 8780$2rvk
100 1 $aFerguson, Niall,$cBSc.
245 10 $aOsteoporosis in focus /$cNiall Ferguson.
260 $aLondon ;$aChicago :$bPharmaceutical Press,$c©2004.
300 $axv, 229 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
520 $aOsteoporosis is a major healthcare problem, affecting the lives of many individuals worldwide. In the UK alone, over 200,000 osteoporosis-related fractures occur annually - a figure that is set to increase as the population ages. Pharmacists see many patients with osteoporosis, and thus will benefit from a deeper understanding of this disease. Osteoporosis in Focus contains a clear, concise discussion of osteoporosis and reviews the role of the pharmacist in counselling patients on their illness, lifestyle and medicines. Chapter topics include prevention, monitoring the condition, interventions, drug treatment, hormone replacement therapy, bisphosphonates, and screening. The third book of the 'in Focus' series, Osteoporosis in Focus should be read by all pharmacists as well as by healthcare professionals with an interest in osteoporosis. (Product Description).
505 0 $a1. Introduction -- 2. Osteoporosis -- 3. Prevention of osteoporosis -- 4. Lifestyle factors -- 5. Monitoring the condition -- 6. Clinical interventions -- 7. Drug treatments -- 8. Calcium and vitamin D -- 9. Hormone replacement therapy -- 10. Biphosphonates -- 11. The future -- 12. Osteoporosis screening -- 13. Pharmaceutical care of the osteoporotic patient.
650 0 $aOsteoporosis$xTreatment.
650 12 $aOsteoporosis$xdrug therapy.
650 6 $aOstéoporose.
650 6 $aOstéoporose$xTraitement.
650 6 $aOstéoporose$xChimiothérapie.
650 7 $aOsteoporosis$xTreatment.$2fast$0(OCoLC)fst01048829
938 $aBaker & Taylor$bBKTY$c55.00$d55.00$i0853694834$n0004271532$sactive
938 $aBaker and Taylor$bBTCP$nBK0004271532
938 $aYBP Library Services$bYANK$n100286396
029 0 $aNLM$b101219046
029 1 $aAU@$b000023211749
029 1 $aDEBBG$bBV021778642
029 1 $aNZ1$b10619442
029 1 $aYDXCP$b100286396
994 $aZ0$bP4A
948 $hHELD BY P4A - 68 OTHER HOLDINGS